You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》美因基因(06667.HK)今起招股 入場費4,444.35元
阿思達克 06-10 08:51
內地基因檢測平台公司美因基因(06667.HK)今日(10日)開始招股,全球共發售約1,196萬股,其中香港公開發售佔約10%,招股價介乎18至22元,以招股價中位數計,料淨籌約1.9億元。每手200股,計及手續費,入場費4,444.35元。招股於下星期三(15日)中午十二時正結束,預期6月15日定價,股份預計於6月22日開始於聯交所掛牌。中信建投國際為獨家保薦人。 公司計劃,將全球發售所得款項淨額約30%用於消費級基因檢測及癌症篩查服務及產品的銷售、營銷及商業化;約25%將投資於研發服務及產品;約20%將用於增加或擴大檢測能力及產能;約15%將用於通過投資或收購具吸引力的技術或檢測相關公司;約10%將用作營運資金及其他一般企業用途。 南昌金融、南昌工控園區及內地臨床體外診斷產品生產商邁克生物(300463.SZ)為基石投資者,認購額分別2,970萬、6,930萬及4,950萬元人民幣。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account